Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer.
Support Care Cancer
; 31(10): 581, 2023 Sep 20.
Article
in En
| MEDLINE
| ID: mdl-37728795
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Breast Neoplasms
/
Carcinoma, Non-Small-Cell Lung
/
Biosimilar Pharmaceuticals
/
Febrile Neutropenia
/
Lung Neoplasms
Type of study:
Etiology_studies
/
Guideline
/
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Female
/
Humans
Language:
En
Journal:
Support Care Cancer
Journal subject:
NEOPLASIAS
/
SERVICOS DE SAUDE
Year:
2023
Document type:
Article
Affiliation country:
Suiza